Zanidatamab (Baihe’an®): Un avance clave en el cáncer de vías biliares HER2 positivo

📩 info@dengyuemed.com
🔗https://dengyuepharma.com

#Zanidatamab #BaiheAn #HER2 #BiliaryTractCancer #Oncology #BispecificAntibody #TargetedTherapy #BreakthroughTherapy #CSCO #CDE #FDA

Jazz Pharmaceuticals Engages in Significant Investor Events for 2026 Jazz Pharmaceuticals has announced its participation in key investor events in early 2026, showcasing its latest advancements and strategies in healthcare.

Jazz Pharmaceuticals Engages in Significant Investor Events for 2026 #Ireland #Dublin #investor_events #Jazz_Pharmaceuticals #Zanidatamab

Jazz Pharmaceuticals Sets the Stage for 2026 with Key Investor Events and Insights Jazz Pharmaceuticals is gearing up for significant investor events in January 2026, showcasing pivotal oncology research and corporate strategy.

Jazz Pharmaceuticals Sets the Stage for 2026 with Key Investor Events and Insights #Ireland #Dublin #investor_events #Jazz_Pharmaceuticals #Zanidatamab

🚨 #Zanidatamab Injection (#ZIIHERA) aprobado en China
💉 Para cáncer biliar HER2+ avanzado
⏳ Para pacientes con tratamientos previos
📎 Más información: dengyuemed.com/product/zani...
📧 info@dengyuemed.com

#CancerBiliarHER2 #CancerBiliarAvanzado #CancerBiliarMetastasico #DengYueMedicinasEnHongKong

Zanidatamab Plus Chemotherapy for HER2-Positive GEA Zanidatamab plus chemotherapy's potential in treating HER2-positive advanced gastro-oesophageal adenocarcinoma with promising efficacy

New Paper Alert: Zanidatamab Plus Chemotherapy for HER2-Positive Gastro-Oesophageal Adenocarcinoma

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Zanidatamab #Chemotherapy #GastroOesophagealAdenocarcinoma #GIOnc

EC approves Jazz Pharmaceuticals’ Ziihera for advanced biliary tract cancer - PMLiVE Approximately 26% of biliary tract cancer patients globally have HER2-positive disease

#gastrointestinalcancers #EC #JazzPharmaceuticals #Ziihera #zanidatamab #advancedbiliarytractcancer #biliarytractcancer #BTCpatients #HER2targetedbispecificantibody #HERIZONBTC01trial #gallbladdercancer #cholangiocarcinoma #advancedHER2positiveBTC #HER2targetedtherapy
pmlive.com/pharma_news/...

Jazz Pharmaceuticals Announces Encouraging Survival Data for Ziihera® in Cancer Treatment at ASCO 2025 Jazz Pharmaceuticals shared promising long-term survival data for Ziihera®, showing a median overall survival of 36.5 months in patients treated for HER2-positive metastatic gastroesophageal adenocarcinoma at ASCO 2025.

Jazz Pharmaceuticals Announces Encouraging Survival Data for Ziihera® in Cancer Treatment at ASCO 2025 #ZIIHERA #Ireland #Dublin #Jazz_Pharmaceuticals #Zanidatamab

Primary results from a phase 2a study show #Zanidatamab + #Palbociclib + #Fulvestrant is a promising chemotherapy-free option for heavily pretreated HR+/HER2+ MBC patients.

@thelancetoncol.bsky.social

#Onco404 #Cancer #Kanser #BreastCancer #ClinicalTrials #HER2 #ADC #TDXd #Healthcare #Innovation

📊 Key Findings
✅ #Zanidatamab demonstrated significant benefit, achieving a mPFS of 6.7 months.
✅ Patients with high HER2 expression (IHC 3+) had a significantly better mPFS (8 months) compared to those with IHC 2+ (confirmed by FISH/NGS) (1.4 months)

#Onco404 #Cancer #Kanser #MedSky #OncSky

Jazz Pharmaceuticals Gains Positive CHMP Opinion for Zanidatamab in Treating Advanced HER2-Positive Biliary Tract Cancer Jazz Pharmaceuticals announces a positive opinion from the CHMP regarding zanidatamab, a potential treatment for advanced HER2-positive biliary tract cancer.

Jazz Pharmaceuticals Gains Positive CHMP Opinion for Zanidatamab in Treating Advanced HER2-Positive Biliary Tract Cancer #Ireland #Dublin #Jazz_Pharmaceuticals #HER2-positive #Zanidatamab

Arndt Vogel: Efficacy of zanidatamab in HER2 positive advanced biliary tract cancers - OncoDaily Arndt Vogel: Efficacy of zanidatamab in HER2 positive advanced biliary tract cancers / Arndt Vogel, Biliary tract cancers, cancer, 𝐄𝐧𝐝𝐨𝐜𝐫𝐢𝐧𝐨𝐥𝐨𝐠𝐲, fight

Efficacy of zanidatamab in HER2-positive advanced biliary tract cancers - Arndt Vogel
@arndtvogel.bsky.social

oncodaily.com/science/2780...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #BiliaryTractCancers #Zanidatamab

#GISeries: #Zanidatamab was recently approved based off #HerizonBTC01! We 🗣️ design, findings, sequencing and AEs/management with Dr. Shubham Pant

Full Discussion:
- Oncbrothers.com/zanidatamab-...
- Also on the “Oncology Brothers” podcast

#OncSky #MedSky #gism #GI25

(1/2) NEW🚨: The @fda.gov has approved the drug #zanidatamab to treat advanced and metastatic #bileductcancer and other biliary tract cancers that have high levels of a protein called #HER2 and do not respond to chemotherapy.

#Zanidatamab (bispecific antibody against Her2) now FDa approved for unresectable/metastatic HER2+ biliary tract cancer based #HerizonBTC01:

- Single arm Ph2B study, 20 mg/kg IV Q2W
- mDoR 14.9mos
- mOS 15.5mos
- AEs: Diarrhea, ⬇️EF
- Do you get Her2 IHC on all Bx?

#gism #OncSky #MedSky